TY - JOUR AU - Fulop, T. AU - Larbi, A. AU - Witkowski, J. M. AU - Kotb, R. AU - Hirokawa, K. AU - Pawelec, G. PY - 2013 DA - 2013// TI - Immunosenescence and cancer JO - Crit Rev Oncog VL - 18 UR - https://doi.org/10.1615/CritRevOncog.2013010597 DO - 10.1615/CritRevOncog.2013010597 ID - Fulop2013 ER - TY - JOUR AU - Du, X. L. AU - Osborne, C. AU - Goodwin, J. S. PY - 2002 DA - 2002// TI - Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.05.088 DO - 10.1200/JCO.2002.05.088 ID - Du2002 ER - TY - JOUR AU - Pallis, A. G. AU - Hatse, S. AU - Brouwers, B. AU - Pawelec, G. AU - Falandry, C. AU - Wedding, U. PY - 2014 DA - 2014// TI - Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging? JO - J Geriatr Oncol VL - 5 UR - https://doi.org/10.1016/j.jgo.2013.09.001 DO - 10.1016/j.jgo.2013.09.001 ID - Pallis2014 ER - TY - JOUR AU - Aapro, M. AU - Wildiers, H. PY - 2012 DA - 2012// TI - Triple-negative breast cancer in the older population JO - Ann Oncol VL - 23 Suppl 6 ID - Aapro2012 ER - TY - JOUR AU - Wildiers, H. PY - 2014 DA - 2014// TI - Adjuvant chemotherapy in older breast cancer patients: how to decide JO - J Geriatr Oncol VL - 5 Suppl 1 UR - https://doi.org/10.1016/j.jgo.2014.06.011 DO - 10.1016/j.jgo.2014.06.011 ID - Wildiers2014 ER - TY - JOUR AU - Wildiers, H. AU - Brain, E. PY - 2015 DA - 2015// TI - Different adjuvant chemotherapy regimens in older breast cancer patients? JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv015 DO - 10.1093/annonc/mdv015 ID - Wildiers2015 ER - TY - JOUR AU - Desai, S. AU - Landay, A. PY - 2010 DA - 2010// TI - Early immune senescence in HIV disease JO - Curr HIV/AIDS Rep VL - 7 UR - https://doi.org/10.1007/s11904-009-0038-4 DO - 10.1007/s11904-009-0038-4 ID - Desai2010 ER - TY - JOUR AU - Pawelec, G. AU - Derhovanessian, E. AU - Larbi, A. PY - 2010 DA - 2010// TI - Immunosenescence and cancer JO - Crit Rev Oncol Hematol VL - 75 UR - https://doi.org/10.1016/j.critrevonc.2010.06.012 DO - 10.1016/j.critrevonc.2010.06.012 ID - Pawelec2010 ER - TY - JOUR AU - Fulop, T. AU - Larbi, A. AU - Hirokawa, K. AU - Mocchegiani, E. AU - Lesourds, B. AU - Castle, S. PY - 2007 DA - 2007// TI - Immunosupportive therapies in aging JO - Clin Interv Aging VL - 2 UR - https://doi.org/10.2147/ciia.2007.2.1.33 DO - 10.2147/ciia.2007.2.1.33 ID - Fulop2007 ER - TY - JOUR AU - Larbi, A. AU - Franceschi, C. AU - Mazzatti, D. AU - Solana, R. AU - Wikby, A. AU - Pawelec, G. PY - 2008 DA - 2008// TI - Aging of the immune system as a prognostic factor for human longevity JO - Physiology (Bethesda) VL - 23 UR - https://doi.org/10.1152/physiol.00040.2007 DO - 10.1152/physiol.00040.2007 ID - Larbi2008 ER - TY - JOUR AU - Fagnoni, F. F. AU - Vescovini, R. AU - Passeri, G. AU - Bologna, G. AU - Pedrazzoni, M. AU - Lavagetto, G. PY - 2000 DA - 2000// TI - Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging JO - Blood VL - 95 ID - Fagnoni2000 ER - TY - JOUR AU - Morel, Y. AU - Truneh, A. AU - Sweet, R. W. AU - Olive, D. AU - Costello, R. T. PY - 2001 DA - 2001// TI - The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity JO - J Immunol VL - 167 UR - https://doi.org/10.4049/jimmunol.167.5.2479 DO - 10.4049/jimmunol.167.5.2479 ID - Morel2001 ER - TY - JOUR AU - Sharma, S. AU - Dominguez, A. L. AU - Lustgarten, J. PY - 2006 DA - 2006// TI - Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB JO - Exp Gerontol VL - 41 UR - https://doi.org/10.1016/j.exger.2005.10.002 DO - 10.1016/j.exger.2005.10.002 ID - Sharma2006 ER - TY - JOUR AU - Huang, H. AU - Patel, D. D. AU - Manton, K. G. PY - 2005 DA - 2005// TI - The immune system in aging: roles of cytokines, T cells and NK cells JO - Front Biosci. VL - 10 UR - https://doi.org/10.2741/1521 DO - 10.2741/1521 ID - Huang2005 ER - TY - JOUR AU - Pawelec, G. AU - Lustgarten, J. AU - Ruby, C. AU - Gravekamp, C. PY - 2009 DA - 2009// TI - Impact of aging on cancer immunity and immunotherapy JO - Cancer Immunol Immunother VL - 58 UR - https://doi.org/10.1007/s00262-009-0743-2 DO - 10.1007/s00262-009-0743-2 ID - Pawelec2009 ER - TY - JOUR AU - Malas, S. AU - Harrasser, M. AU - Lacy, K. E. AU - Karagiannis, S. N. PY - 2014 DA - 2014// TI - Antibody therapies for melanoma: New and emerging opportunities to activate immunity (Review) JO - Oncol Rep VL - 32 ID - Malas2014 ER - TY - JOUR AU - Page, D. B. AU - Postow, M. A. AU - Callahan, M. K. AU - Wolchok, J. D. PY - 2013 DA - 2013// TI - Checkpoint modulation in melanoma: an update on ipilimumab and future directions JO - Curr Oncol Rep VL - 15 UR - https://doi.org/10.1007/s11912-013-0337-1 DO - 10.1007/s11912-013-0337-1 ID - Page2013 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Weide, B. AU - Zelba, H. AU - Derhovanessian, E. AU - Pflugfelder, A. AU - Eigentler, T. K. AU - Giacomo, A. M. PY - 2012 DA - 2012// TI - Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.40.2271 DO - 10.1200/JCO.2011.40.2271 ID - Weide2012 ER - TY - JOUR AU - Zelba, H. AU - Weide, B. AU - Martens, A. AU - Derhovanessian, E. AU - Bailur, J. K. AU - Kyzirakos, C. PY - 2014 DA - 2014// TI - Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-1015 DO - 10.1158/1078-0432.CCR-14-1015 ID - Zelba2014 ER - TY - JOUR AU - Bailur, J. K. AU - Gueckel, B. AU - Derhovanessian, E. AU - Pawelec, G. PY - 2015 DA - 2015// TI - Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients JO - Breast Cancer Res. VL - 17 UR - https://doi.org/10.1186/s13058-015-0541-z DO - 10.1186/s13058-015-0541-z ID - Bailur2015 ER - TY - JOUR AU - Bonertz, A. AU - Weitz, J. AU - Pietsch, D. H. AU - Rahbari, N. N. AU - Schlude, C. AU - Ge, Y. PY - 2009 DA - 2009// TI - Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma JO - J Clin Invest VL - 119 ID - Bonertz2009 ER - TY - JOUR AU - Vence, L. AU - Palucka, A. K. AU - Fay, J. W. AU - Ito, T. AU - Liu, Y. J. AU - Banchereau, J. PY - 2007 DA - 2007// TI - Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0710557105 DO - 10.1073/pnas.0710557105 ID - Vence2007 ER - TY - JOUR AU - Chen, W. C. AU - Lai, Y. H. AU - Chen, H. Y. AU - Guo, H. R. AU - Su, I. J. AU - Chen, H. H. PY - 2013 DA - 2013// TI - Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor JO - Histopathology VL - 63 UR - https://doi.org/10.1111/his.12156 DO - 10.1111/his.12156 ID - Chen2013 ER - TY - JOUR AU - Zaynagetdinov, R. AU - Sherrill, T. P. AU - Gleaves, L. A. AU - McLoed, A. G. AU - Saxon, J. A. AU - Habermann, A. C. PY - 2015 DA - 2015// TI - Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2379 DO - 10.1158/0008-5472.CAN-14-2379 ID - Zaynagetdinov2015 ER - TY - JOUR AU - Simson, L. AU - Ellyard, J. I. AU - Dent, L. A. AU - Matthaei, K. I. AU - Rothenberg, M. E. AU - Foster, P. S. PY - 2007 DA - 2007// TI - Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance JO - J Immunol VL - 178 UR - https://doi.org/10.4049/jimmunol.178.7.4222 DO - 10.4049/jimmunol.178.7.4222 ID - Simson2007 ER - TY - JOUR AU - Derhovanessian, E. AU - Adams, V. AU - Hahnel, K. AU - Groeger, A. AU - Pandha, H. AU - Ward, S. PY - 2009 DA - 2009// TI - Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients JO - Int J Cancer VL - 125 UR - https://doi.org/10.1002/ijc.24497 DO - 10.1002/ijc.24497 ID - Derhovanessian2009 ER - TY - JOUR AU - Middleton, G. W. AU - Annels, N. E. AU - Pandha, H. S. PY - 2012 DA - 2012// TI - Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? JO - Cancer Immunol Immunother VL - 61 UR - https://doi.org/10.1007/s00262-011-1151-y DO - 10.1007/s00262-011-1151-y ID - Middleton2012 ER - TY - JOUR AU - Benevides, L. AU - Cardoso, C. R. AU - Tiezzi, D. G. AU - Marana, H. R. AU - Andrade, J. M. AU - Silva, J. S. PY - 2013 DA - 2013// TI - Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor JO - Eur J Immunol VL - 43 UR - https://doi.org/10.1002/eji.201242951 DO - 10.1002/eji.201242951 ID - Benevides2013 ER - TY - JOUR AU - Chatterjee, S. AU - Das, S. AU - Chakraborty, P. AU - Manna, A. AU - Chatterjee, M. AU - Choudhuri, S. K. PY - 2013 DA - 2013// TI - Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naive CD4+ T cells JO - Immunobiology VL - 218 UR - https://doi.org/10.1016/j.imbio.2012.08.271 DO - 10.1016/j.imbio.2012.08.271 ID - Chatterjee2013 ER - TY - JOUR AU - Fujisawa, T. AU - Joshi, B. H. AU - Puri, R. K. PY - 2012 DA - 2012// TI - IL-13 regulates cancer invasion and metastasis through IL-13Ralpha2 via ERK/AP-1 pathway in mouse model of human ovarian cancer JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.26366 DO - 10.1002/ijc.26366 ID - Fujisawa2012 ER - TY - JOUR AU - Goldstein, R. AU - Hanley, C. AU - Morris, J. AU - Cahill, D. AU - Chandra, A. AU - Harper, P. PY - 2011 DA - 2011// TI - Clinical investigation of the role of interleukin-4 and interleukin-13 in the evolution of prostate cancer JO - Cancers (Basel) VL - 3 UR - https://doi.org/10.3390/cancers3044281 DO - 10.3390/cancers3044281 ID - Goldstein2011 ER - TY - JOUR AU - Roca, H. AU - Craig, M. J. AU - Ying, C. AU - Varsos, Z. S. AU - Czarnieski, P. AU - Alva, A. S. PY - 2012 DA - 2012// TI - IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation JO - J Cell Biochem VL - 113 ID - Roca2012 ER - TY - JOUR AU - Voronov, E. AU - Shouval, D. S. AU - Krelin, Y. AU - Cagnano, E. AU - Benharroch, D. AU - Iwakura, Y. PY - 2003 DA - 2003// TI - IL-1 is required for tumor invasiveness and angiogenesis JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.0437939100 DO - 10.1073/pnas.0437939100 ID - Voronov2003 ER - TY - JOUR AU - Salgado, R. AU - Junius, S. AU - Benoy, I. AU - Dam, P. AU - Vermeulen, P. AU - Marck, E. PY - 2003 DA - 2003// TI - Circulating interleukin-6 predicts survival in patients with metastatic breast cancer JO - Int J Cancer VL - 103 UR - https://doi.org/10.1002/ijc.10833 DO - 10.1002/ijc.10833 ID - Salgado2003 ER - TY - JOUR AU - Ikeda, H. AU - Old, L. J. AU - Schreiber, R. D. PY - 2002 DA - 2002// TI - The roles of IFN gamma in protection against tumor development and cancer immunoediting JO - Cytokine Growth Factor Rev VL - 13 UR - https://doi.org/10.1016/S1359-6101(01)00038-7 DO - 10.1016/S1359-6101(01)00038-7 ID - Ikeda2002 ER - TY - JOUR AU - Rosenberg, S. A. AU - Lotze, M. T. AU - Muul, L. M. AU - Chang, A. E. AU - Avis, F. P. AU - Leitman, S. PY - 1987 DA - 1987// TI - A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone JO - N Engl J Med VL - 316 UR - https://doi.org/10.1056/NEJM198704093161501 DO - 10.1056/NEJM198704093161501 ID - Rosenberg1987 ER - TY - JOUR AU - Kaplan, D. H. AU - Shankaran, V. AU - Dighe, A. S. AU - Stockert, E. AU - Aguet, M. AU - Old, L. J. PY - 1998 DA - 1998// TI - Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.13.7556 DO - 10.1073/pnas.95.13.7556 ID - Kaplan1998 ER - TY - JOUR AU - Street, S. E. AU - Cretney, E. AU - Smyth, M. J. PY - 2001 DA - 2001// TI - Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis JO - Blood VL - 97 UR - https://doi.org/10.1182/blood.V97.1.192 DO - 10.1182/blood.V97.1.192 ID - Street2001 ER - TY - JOUR AU - Vadhan-Raj, S. AU - Al-Katib, A. AU - Bhalla, R. AU - Pelus, L. AU - Nathan, C. F. AU - Sherwin, S. A. PY - 1986 DA - 1986// TI - Phase I trial of recombinant interferon gamma in cancer patients JO - J Clin Oncol VL - 4 ID - Vadhan-Raj1986 ER - TY - JOUR AU - Windbichler, G. H. AU - Hausmaninger, H. AU - Stummvoll, W. AU - Graf, A. H. AU - Kainz, C. AU - Lahodny, J. PY - 2000 DA - 2000// TI - Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial JO - Br J Cancer VL - 82 UR - https://doi.org/10.1054/bjoc.1999.1053 DO - 10.1054/bjoc.1999.1053 ID - Windbichler2000 ER - TY - JOUR AU - Horssen, R. AU - Hagen, T. L. AU - Eggermont, A. M. PY - 2006 DA - 2006// TI - TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility JO - Oncologist VL - 11 UR - https://doi.org/10.1634/theoncologist.11-4-397 DO - 10.1634/theoncologist.11-4-397 ID - Horssen2006 ER -